Seoul Metropolitan Government Seoul National University Boramae Medical Center — Seoul

Public research footprint of Seoul Metropolitan Government Seoul National University Boramae Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) · Ischemic Stroke · Chronic Obstructive Pulmonary Disease (COPD) · HER2 Negative Breast Neoplasms

Recently updated registry entries

NCT07746895 — Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A… (Recruiting)
NCT05153239 — Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus… (Completed)
NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Seoul Metropolitan Government Seoul National University Boramae Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.